Gozetotide

Gozetotide, also known as DOTA-TOC or DOTATOC, is a synthetic peptide designed as a somatostatin analog conjugated with a chelating agent, DOTA. This innovative compound exhibits high affinity for somatostatin receptor subtype 2 (SSTR2), making it a valuable tool in various research and imaging applications. Gozetotide's unique structure enables it to form stable complexes with a range of radiometals, facilitating its use in molecular imaging and targeted studies. Its robust receptor-binding capabilities, combined with its versatility in labeling, have led to widespread adoption in preclinical and translational research. The peptide's stability and specificity further contribute to its utility, allowing for precise investigation of somatostatin receptor biology and the development of novel diagnostic strategies. Researchers appreciate gozetotide for its reliability and adaptability in experimental design, as it enables the exploration of receptor expression, biodistribution, and targeted delivery in diverse biological systems.

Molecular Imaging Research: In the realm of molecular imaging, gozetotide serves as a critical probe for visualizing somatostatin receptor-expressing tissues. By labeling the compound with suitable radiometals, such as gallium-68 or indium-111, scientists can perform highly sensitive positron emission tomography (PET) or single-photon emission computed tomography (SPECT) studies. This approach allows for the noninvasive assessment of receptor distribution and density in animal models, facilitating the study of receptor-mediated signaling pathways and disease progression. The high receptor affinity and favorable pharmacokinetics of gozetotide ensure clear imaging contrast and minimal background signal, supporting accurate quantification and spatial localization of target tissues.

Receptor Expression Analysis: Gozetotide plays an instrumental role in the quantitative analysis of somatostatin receptor expression across various cell lines and tissue samples. Utilizing radiolabeled or fluorescently tagged forms of the peptide, researchers can perform in vitro binding assays, autoradiography, and flow cytometry to determine receptor density and distribution patterns. These studies are essential for understanding receptor regulation, ligand-receptor interactions, and cellular responses to pharmacological agents. The ability of gozetotide to selectively bind SSTR2 enables precise mapping of receptor populations, advancing knowledge in neuroendocrine biology and receptor-targeted research.

Pharmacokinetic and Biodistribution Studies: The compound is widely employed in pharmacokinetic and biodistribution investigations to evaluate the in vivo behavior of somatostatin analogs and other receptor-targeted agents. By tracking radiolabeled gozetotide in animal models, researchers can monitor tissue uptake, clearance rates, and metabolic stability over time. These data provide valuable insights into the dynamics of receptor-ligand interactions and inform the optimization of dosing regimens for experimental compounds. Such studies contribute to the rational design of novel peptides and radiopharmaceuticals with improved targeting characteristics.

Radiometal Chelation Research: The DOTA chelator component of gozetotide makes it a preferred scaffold for radiometal complexation studies. Scientists explore the coordination chemistry of various radiometals with the peptide to assess labeling efficiency, stability, and in vivo retention. These investigations are crucial for developing new radiotracers and optimizing labeling protocols for molecular imaging and targeted delivery. The versatility of gozetotide in accommodating different metal ions expands the toolkit available for radiopharmaceutical research and enhances the potential for multimodal imaging approaches.

Targeted Delivery System Development: Researchers leverage gozetotide's receptor specificity to design targeted delivery systems for experimental therapeutics and imaging agents. By conjugating the peptide to nanoparticles, liposomes, or other carrier platforms, it becomes possible to direct payloads selectively to SSTR2-expressing cells. This strategy enhances the accumulation of bioactive compounds at the site of interest while minimizing off-target effects, thereby improving the efficacy and safety profiles of investigational agents. The use of gozetotide in targeted delivery research paves the way for innovative approaches to disease modeling and the evaluation of novel drug delivery technologies.

1. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis